Related Experiment Video
Updated: Jun 6, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The cardiorenal syndrome: making the connection
Gautham Viswanathan1, Scott Gilbert
1Division of Nephrology, Tufts Medical Center, 800 Washington Street, P.O. 391, Boston, MA 02111, USA.
Insights
Cardiorenal syndrome (CRS) involves heart and kidney dysfunction. Type 1 CRS occurs when acute decompensated heart failure causes acute kidney injury due to reduced kidney filtration and perfusion.
Area of Science:
- Cardiology
- Nephrology
- Physiology
Background:
- The heart and kidneys are interdependent for maintaining hemodynamic stability and organ perfusion.
- Underlying heart or kidney disease compromises the compensatory mechanisms between these organs.
- This interaction has led to the characterization of cardiorenal syndrome (CRS).
Purpose of the Study:
- To review cardiorenal syndrome (CRS), focusing on Type 1.
- To examine the scope, impact, and pathophysiology of CRS Type 1.
- To discuss diagnostic tools and therapeutic interventions for CRS Type 1.
Main Methods:
- Review of existing literature on cardiorenal syndrome.
- Analysis of the pathophysiology linking acute decompensated heart failure and acute kidney injury.
- Synthesis of information on diagnostic and therapeutic strategies.
Main Results:
- Acute decompensated heart failure (ADHF) can precipitate acute kidney injury (AKI) via hemodynamic and neurohormonal pathways.
- Underperfusion and venous congestion are key pathophysiological mechanisms in CRS Type 1.
- Early detection and intervention are crucial for managing CRS Type 1.
Conclusions:
- CRS Type 1 represents a significant complication of acute decompensated heart failure.
- Understanding the interplay between cardiac and renal systems is vital for effective management.
- Further research into diagnostic and therapeutic strategies is warranted to improve patient outcomes.
Abstract:
The heart and the kidneys share responsibility for maintaining hemodynamic stability and end-organ perfusion. Connections between these organs ensure that subtle physiologic changes in one system are tempered by compensation in the other through a variety of pathways and mediators. In the setting of underlying heart disease or chronic kidney disease, the capacity of each organ to respond to perturbation caused by the other may become compromised. This has recently led to the characterization of the cardiorenal syndrome (CRS). This review will primarily focus on CRS type 1 where acute decompensated heart failure (ADHF) results in activation of hemodynamic and neurohormonal factors leading to an acute drop in the glomerular filtration rate and the development of acute kidney injury. We will examine the scope and impact of this problem, the pathophysiology associated with this relationship, including underperfuson and venous congestion, diagnostic tools for earlier detection, and therapeutic interventions to prevent and treat this complication.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Diuretics
Hypertension II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
